{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:20:56Z","timestamp":1783354856189,"version":"3.54.6"},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Introduction<\/jats:bold>\n                    : Standard dialysate sodium concentration (sDNa) may not adequately reflect individual sodium requirements in each hemodialysis patient, potentially contributing to interdialytic weight gain (IDWG), hypertension and inflammation. The aim of this study was to compare clinical and biochemical outcomes between individualized and standard dialysate sodium prescriptions and to assess factors associated with mortality.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Materials and Methods<\/jats:bold>\n                    : This was a prospective interventional study conducted in two phases. In the first phase, patients were treated with standard hemodialysis (HD) using a fixed dialysate sodium concentration of 138 mmol\/L. In the second phase, dialysate sodium was individualized based on each patient\u2019s pre-dialysis serum sodium concentration. Each patient served as their own control. Outcomes included IDWG, blood pressure, thirst score, dialysis adequacy (Kt\/V, URR), nutritional markers, C-reactive protein (CRP), electrolytes, and mortality.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results<\/jats:bold>\n                    : Individualized dialysate sodium prescription was associated with a significant reduction in IDWG (1.93 \u00b1 0.64 vs 2.17 \u00b1 0.79 kg; p = 0.001) and improved dialysis adequacy (Kt\/V: 1.50 \u00b1 0.24 vs 1.36 \u00b1 0.22; p &lt; 0.001). Survivors had higher serum albumin levels and lower CRP values compared to non-survivors. Serum and dialysate sodium concentrations were not independently associated with mortality. In logistic regression analysis, CRP &gt;10 mg\/L showed the strongest observed association with mortality (OR 10.278; 95% CI 1.709\u201361.826; p = 0.011).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion<\/jats:bold>\n                    : Individualized dialysate sodium prescription may improve fluid control and dialysis adequacy in selected patients. Inflammation was significantly associated with mortality in this cohort; however, results should be interpreted with caution due to the limited number of events.\n                  <\/jats:p>","DOI":"10.2478\/prilozi-2026-0026","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:13:28Z","timestamp":1783350808000},"page":"137-145","source":"Crossref","is-referenced-by-count":0,"title":["Beyond Sodium: Inflammation as the Strongest Predictor of Mortality Among Non-Diabetic Hemodialysis Patients"],"prefix":"10.2478","volume":"47","author":[{"given":"Natasha","family":"Eftimovska-Otovikj","sequence":"first","affiliation":[{"name":"General City Hospital \u201c8th September\u201d , Skopje , RN Macedonia"},{"name":"Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeta","family":"Poposka","sequence":"additional","affiliation":[{"name":"General City Hospital \u201c8th September\u201d , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Popovska","sequence":"additional","affiliation":[{"name":"General City Hospital \u201c8th September\u201d , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlina","family":"Dzekova-Vidimliski","sequence":"additional","affiliation":[{"name":"University Clinic for Nephrology , Skopje , RN Macedonia"},{"name":"Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Gjorgjievski","sequence":"additional","affiliation":[{"name":"University Clinic for Nephrology , Skopje , RN Macedonia"},{"name":"Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlatko","family":"Karanfilovski","sequence":"additional","affiliation":[{"name":"University Clinic for Nephrology , Skopje , RN Macedonia"},{"name":"Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjulsen","family":"Selim","sequence":"additional","affiliation":[{"name":"University Clinic for Nephrology , Skopje , RN Macedonia"},{"name":"Faculty of Medicine , Ss. Cyril and Methodius University in Skopje , Skopje , RN Macedonia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"2026070616021105683_j_prilozi-2026-0026_ref_001","doi-asserted-by":"crossref","unstructured":"Fleming M Geoffrey. Renal replacement therapy review. Organogenesis. 2011;7(1):2\u201312","DOI":"10.4161\/org.7.1.13997"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_002","doi-asserted-by":"crossref","unstructured":"Twardowski J Zbylut. History of hemodialyzers\u2019 designs. Hemodial Int. 2008; 12(2):173-210","DOI":"10.1111\/j.1542-4758.2008.00253.x"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_003","doi-asserted-by":"crossref","unstructured":"Flythe E. J, Mc Causland R. F.Dialysate Sodium: Rationale for Evolution over Time. Semin Dial. 2017;30(2):99\u2013111","DOI":"10.1111\/sdi.12570"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_004","doi-asserted-by":"crossref","unstructured":"Santos S. and Peixoto A. Revisiting the dial-ysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol. 2008; 3: 522-530","DOI":"10.2215\/CJN.03360807"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_005","doi-asserted-by":"crossref","unstructured":"Tomson R.V.C. Advising dialysis patient to restrict fluid intake without restricting sodium in-take is not based on evidence and is a waste of time. Nephrol Dial Transplant. 2001; 16: 1538-1542","DOI":"10.1093\/ndt\/16.8.1538"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_006","doi-asserted-by":"crossref","unstructured":"A Bruzda-Zwiech, J Szczepa\u0144ska, R Zwiech. Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients. Med Oral Patol Oral Cir Bucal. 2018; 23(4): 406-412","DOI":"10.4317\/medoral.22294"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_007","doi-asserted-by":"crossref","unstructured":"Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt\/V: an analysis of error. J Am Soc Nephrol. 1993;4(5):1205\u201313","DOI":"10.1681\/ASN.V451205"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_008","unstructured":"Lowrie E. G. et Lew N. L. The urea reduction ratio (URR): a simple method for evaluating hemodialysis treatment. Contemporary Dialysis and Nephrology. 1991;12: 11\u201320"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_009","unstructured":"Causland R, Waikar S. Optimal dialysate sodium\u2014What is the evidence? Semin Dial. 2012;25(3):270\u2013277"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_010","unstructured":"Suckling J, Pierratos A, Greenwood M, Nesrallah G. Reducing sodium in dialysate may reduce thirst and interdialytic weight gain: a randomized controlled trial. Nephrol Dial Transplant. 2017;32(11):1907\u20131914"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_011","unstructured":"Conte G, Capitanini A, Macerata P, et al. Plasma tonicity and potassium homeostasis in hemodialysis patients. Clin J Am Soc Nephrol. 2015;10(5):851\u2013859"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_012","doi-asserted-by":"crossref","unstructured":"Kooman P, Van der Sande F, Leunissen K, Locatelli F. Sodium balance in hemodialysis therapy. Semin Dial. 2003; 16: 351-5","DOI":"10.1046\/j.1525-139X.2003.16070.x"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_013","doi-asserted-by":"crossref","unstructured":"Wizemann V, Wabel P, Chamney P, Zaluska W et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009; 24: 1574-9","DOI":"10.1093\/ndt\/gfn707"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_014","unstructured":"De Nicola L, Bellizzi V, Minutolo R, et al. Sodium removal and extracellular volume in hemodialysis: New insights from segmental bio-impedance analysis. Nephrol Dial Transplant. 2013;28(5):1176\u20131182"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_015","doi-asserted-by":"crossref","unstructured":"De Nicola L, Bellizzi V, Minutolo R. Effect of Dialysate Sodium Concentration on Inter-dialytic Increase of Potassium. JASN, 2000; 11: 2337-2343","DOI":"10.1681\/ASN.V11122337"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_016","unstructured":"Wright S, Hutchison A, Macaulay D et al. Association of serum sodium with morbidity and mortality in hemodialysis patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS).Clinical Journal of the American Society of Nephrology. 2015; 10(1): 122\u2013129"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_017","unstructured":"Causland R., Waikar S, Brunelli M et Tentori F. Dialysate sodium and mortality in maintenance hemodialysis: A prospective cohort study. American Journal of Kidney Diseases.2012; 59(3): 238\u2013245"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_018","unstructured":"Oliva-Damaso N, Oliva-Damaso E, Gomis-Couto A et al. Inflammation and cardiovascular disease in dialysis patients.Nefrolog\u00eda (English Edition). 2018; 38(2): 135\u2013142"},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_019","unstructured":"Suckling J, HeatonJ, PowerA. et Chambers J. Nutritional status and survival in hemodialysis patients: The impact of serum albumin and body mass index. Journal of Renal Nutrition.2017; 27(5): 321\u2013331."},{"key":"2026070616021105683_j_prilozi-2026-0026_ref_020","doi-asserted-by":"crossref","unstructured":"Radhika R, Santosh V, Abitha C, Shibu J. Effects of Individualized Dialysate Sodium Prescription in Hemodialysis \u2013 Results from a Prospective Interventional Trial. Indian J Nephrol. 2019; 30(1): 3\u20137","DOI":"10.4103\/ijn.IJN_391_18"}],"container-title":["PRILOZI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/prilozi-2026-0026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:08:09Z","timestamp":1783354089000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/prilozi-2026-0026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,30]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/prilozi-2026-0026"],"URL":"https:\/\/doi.org\/10.2478\/prilozi-2026-0026","relation":{},"ISSN":["1857-8985"],"issn-type":[{"value":"1857-8985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}